A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder
PHASE3CompletedINTERVENTIONAL
Enrollment
473
Participants
Timeline
Start Date
February 28, 2006
Primary Completion Date
June 30, 2007
Study Completion Date
June 30, 2007
Conditions
Bipolar DisorderMood Disorders
Interventions
DRUG
Paliperidone extended-release
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00299715 - A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder | Biotech Hunter | Biotech Hunter